Brandon Whitefield

机构：Bristol-Myers Squibb (Germany), Bristol-Myers Squibb (United States) · ORCID：0009-0008-4096-429X

发表论文 55 篇 · 总被引 599 次 · h-index 8

代表论文

Discovery of Potent and Selective BCL6 Ligand-Directed Degrader (LDD), BCL6-760 (2025 · Journal of Medicinal Chemistry · 被引 8)
Discovery of BMS-986458, a Potent and Selective B-Cell Lymphoma 6 Protein Ligand-Directed Degrader, for the Treatment of B-Cell Non-Hodgkin Lymphoma (2026 · Journal of Medicinal Chemistry · 被引 2)
Discovery of Potential First-in-Class Dual Ligand-Directed Degrader and Antagonist of the Androgen Receptor: BMS-986365 (2026 · Figshare)
Discovery of Potential First-in-Class Dual Ligand-Directed Degrader and Antagonist of the Androgen Receptor: BMS-986365 (2026 · Figshare)
Discovery of Potential First-in-Class Dual Ligand-Directed Degrader and Antagonist of the Androgen Receptor: BMS-986365 (2026 · Journal of Medicinal Chemistry)
Supplementary Figure S2 from Cereblon-based Bifunctional Degrader of SOS1, BTX-6654, Targets Multiple KRAS Mutations and Inhibits Tumor Growth (2026)